Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

ERBB receptor tyrosine kinases and cellular radiation responses

Abstract

Ionizing radiation induces in autocrine growth-regulated carcinoma and malignant glioma cells powerful cytoprotective responses that confer relative resistance to consecutive radiation exposures. Understanding the mechanisms of these responses should provide new molecular targets for tumor radiosensitization. ERBB and other receptor Tyr kinases have been identified as immediate early response gene products that are activated by radiation within minutes, as by their physiological growth factor ligands, and induce secondary stimulation of cytoplasmic protein kinase cascades. The simultaneous activation of all receptor Tyr kinases and nonreceptor Tyr kinases leads to complex cytoprotective responses including increased cell proliferation, reduced apoptosis and enhanced DNA repair. Since these responses contribute to cellular radioresistance, ERBB1, the most extensively studied ERBB receptor, is examined as a target for tumor cell radiosensitization. The three methods of ERBB1 inhibition include blockade of growth factor binding by monoclonal antibody against the ligand-binding domain, inhibition of the receptor Tyr kinase-mediating receptor activation, and overexpression of a dominant-negative epidermal growth factor receptor-CD533 that lacks the COOH-terminal 533 amino acids and forms nonfunctional heterodimeric complexes with wild-type receptors. All the three approaches enhance radiation toxicity in vitro and in vivo. The different mechanisms of inhibition have contributed to the understanding of cellular responses to radiation, vary in relative effectiveness and pose different challenges for translation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Akimoto T, Hunter NR, Buchmiller L, Mason K, Ang KK and Milas L . (1999). Clin. Cancer Res., 5, 2884–2890.

  • Allen LF, Lenehan PF, Eiseman IA, Elliott WL and Fry DW . (2002). Semin. Oncol., 29, 11–21.

  • Amorino GP, Hamilton VM, Valerie K, Dent P, Lammering G and Schmidt-Ullrich RK . (2002). Mol. Biol. Cell., 13, 2233–2244.

  • Amorino GP, Mikkelsen RB, Valerie K and Schmidt-Ullrich RK . (2003). J. Biol. Chem., (epub ahead of print).

  • Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK and Milas L . (2002). Cancer Res., 62, 7350–7356.

  • Baserga R . (1995). Cancer Res., 55, 249–252.

  • Bentzen SM and Thames HD . (1991). Radiother. Oncol., 22, 161–166.

  • Bernhard EJ, McKenna WG, Hamilton AD, Sebti SM, Qian Y, Wu JM and Muschel RJ . (1998). Cancer Res., 58, 1754–1761.

  • Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH and Parsons SJ . (1999). J. Biol. Chem., 274, 8335–8343.

  • Bonner JA, Raisch KP, Trummell HQ, Robert F, Meredith RF, Spencer SA, Buchsbaum DJ, Saleh MN, Stackhouse MA, LoBuglio AF, Peters GE, Carroll WR and Waksal HW . (2000). J. Clin. Oncol., 18, 47S–53S.

  • Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C and Schmidt-Ullrich RK . (2001). Oncogene, 20, 1388–1397.

  • Carpenter G. (2000). Bioessays, 697–707.

  • Chakravarti A, Loeffler JS and Dyson NJ . (2002). Cancer Res., 62, 200–207.

  • Chou JL, Fan Z, DeBlasio T, Koff A, Rosen N and Mendelsohn J . (1999). Breast Cancer Res. Treat, 55, 267–283.

  • Chu CT, Everiss KD, Wikstrand CJ, Batra SK, Kung HJ and Bigner DD . (1997). Biochem., 324 (Pt 3), 855–861.

  • Contessa JN, Hampton J, Lammering G, Mikkelsen RB, Dent P, Valerie K and Schmidt-Ullrich RK . (2002). Oncogene, 21, 4032–4041.

  • Contessa JN, Reardon DB, Todd D, Dent P, Mikkelsen RB, Valerie K, Bowers GD and Schmidt-Ullrich RK . (1999). Clin. Cancer Res., 5, 405–411.

  • Craggs G and Kellie S . (2001). J. Biol. Chem., 276, 23719–23725.

  • Denekamp J . (1973). Br. J. Radiol., 46, 381–387.

  • Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K and Schmidt-Ullrich R . (1999). Mol. Biol. Cell, 10, 2493–2506.

  • Durand RE . (1993). Semin. Radiat. Oncol., 3, 105–114.

  • Earp HS, Dawson TL, Li X and Yu H . (1995). Breast Cancer Res. Treat., 35, 115–132.

  • Emlet DR, Moscatello DK, Ludlow LB and Wong AJ . (1997). J. Biol. Chem., 272, 4079–4086.

  • Fertil B, Dertinger H, Courdi A and Malaise EP . (1984). Radiat. Res., 99, 73–84.

  • Fowler JF . (1991). Radiother. Oncol., 22, 156–158.

  • Fry DW, Bridges AJ, Denny WA, Doherty A, Greis KD, Hicks JL, Hook KE, Keller PR, Leopold WR, Loo JA, McNamara DJ, Nelson JM, Sherwood V, Smaill JB, Trumpp-Kallmeyer S and Dobrusin EM . (1998). Proc. Natl. Acad. Sci. USA, 95, 12022–12027.

  • Gamett DC, Pearson G, Cerione RA and Friedberg I . (1997). J Biol Chem, 272, 12052–12056.

  • Gotoh N, Toyoda M and Shibuya M . (1997). Mol. Cell Biol., 17, 1824–1831.

  • Harari PM and Huang SM . (2001). Semin. Radiat. Oncol., 11, 281–289.

  • Huang SM, Bock JM and Harari PM . (1999). Cancer Res., 59, 1935–1940.

  • Huang SM and Harari PM . (2000). Clin. Cancer Res., 6, 2166–2174.

  • Huang SM, Li J, Armstrong EA and Harari PM . (2002). Cancer Res., 62, 4300–4306.

  • Kashles O, Yarden Y, Fischer R, Ullrich A and Schlessinger J . (1991). Mol. Cell Biol., 11, 1454–1463.

  • Kasid U and Dritschilo A . (2003). Oncogene Rev., 22, 5876–5884.

  • Kavanagh BD, Lin PS, Chen P and Schmidt-Ullrich RK . (1995). Clin. Cancer Res., 1, 1557–1562.

  • Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K and Bohmer FD . (1998). J. Biol. Chem., 273, 24839–24846.

  • Kuan CT, Reist CJ, Foulon CF, Lorimer IA, Archer G, Pegram CN, Pastan I, Zalutsky MR and Bigner DD . (1999). Clin. Cancer Res., 5, 1539–1549.

  • Lammering G, Hewit TH, Hawkins WT, Contessa JN, Reardon DB, Lin PS, Valerie K, Dent P, Mikkelsen RB and Schmidt-Ullrich RK . (2001a). J. Natl. Cancer Inst., 93, 921–929.

  • Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K and Schmidt-Ullrich RK . (2001b). Int. J. Radiat. Oncol. Biol. Phys., 51, 775–784.

  • Lammering G, Valerie K, Lin PS, Mikkelsen RB, Contessa JN, Feden JP, Farnsworth J, Dent P and Schmidt-Ullrich RK . (2001c). Clin. Cancer Res., 7, 682–690.

  • Lammering G, Hewit TH, Valerie K, Contessa JN, Amorino GP, Dent P and Schmidt-Ullrich RK . (2003). Oncogene (in press).

  • Leach JK, Black SM, Schmidt-Ullrich RK and Mikkelsen RB . (2002). J. Biol. Chem., 277, 15400–15406.

  • Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R and Mikkelsen RB . (2001). Cancer Res., 61, 3894–3901.

  • Lenferink AE, Pinkas-Kramarski R, van de Poll ML, van Vugt MJ, Klapper LN, Tzahar E, Waterman H, Sela M, van Zoelen EJ and Yarden Y . (1998). EMBO J., 17, 3385–3397.

  • Levitzki A . (1997). Med. Oncol., 14, 83–99.

  • Levitzki A, Gazit A, Osherov N, Posner I and Gilon C . (1991). Methods Enzymol., 201, 347–361.

  • Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S and Yarden Y . (1999). Mol. Cell, 4, 1029–1040.

  • McKenna WG, Muschel RJ, Gupta AK, Hahn SM and Bernhard EJ . (2003). Oncogene, 22, 5866–5875.

  • Mendelsohn J and Baselga J . (2000). Oncogene, 19, 6550–6565.

  • Mikkelsen RB and Ward P . (2003). Oncogene Rev. (in press).

  • Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J and Fan Z . (2000). Clin. Cancer Res., 6, 701–708.

  • Nelson JM and Fry DW . (2001). J. Biol. Chem., 276, 14842–11487.

  • O'Rourke DM, Kao GD, Singh N, Park BW, Muschel RJ, Wu CJ and Greene MI . (1998a). Proc. Natl. Acad. Sci. USA, 95, 10842–10847.

  • O'Rourke DM, Nute EJ, Davis JG, Wu C, Lee A, Murali R, Zhang HT, Qian X, Kao CC and Greene MI . (1998b). Oncogene, 16, 1197–1207.

  • Park BW, Zhang HT, Wu C, Berezov A, Zhang X, Dua R, Wang Q, Kao G, O'Rourke DM, Greene MI and Murali R . (2000). Nat. Biotechnol., 18, 194–198.

  • Peretz S, Jensen R, Baserga R and Glazer PM . (2001). Proc. Natl. Acad. Sci. USA, 98, 1676–1681.

  • Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B and Baserga R . (1999). Mol. Cell Biol., 19, 7203–7215.

  • Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ and Slamon DJ . (1999). Cancer Res., 59, 1347–1355.

  • Rao GS, Murray S and Ethier SP . (2000). Int. J. Radiat. Oncol. Biol. Phys., 48, 1519–1528.

  • Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P and Schmidt-Ullrich RK . (1999). Oncogene, 18, 4756–4766.

  • Rojas M, Yao S and Lin YZ . (1996). J. Biol. Chem., 271, 27456–27461.

  • Roudabush FL, Pierce KL, Maudsley S, Khan KD and Luttrell LM . (2000). J. Biol. Chem., 275, 22583–22589.

  • Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G and Lin PS . (1999). Radiat. Oncol. Investig., 7, 321–330.

  • Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB and Valerie K . (2000). Radiat. Res., 153, 245–257.

  • Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK and Chen PB . (1997). Oncogene, 15, 1191–1197.

  • Schmidt-Ullrich RK, Valerie K, Fogleman PB and Walters J . (1996). Radiat. Res., 145, 81–85.

  • Schmidt-Ullrich RK, Valerie KC, Chan W and McWilliams D . (1994). Int. J. Radiat. Oncol. Biol. Phys., 29, 813–819.

  • Shah BH, Farshori MP, Jambusaria A and Catt KJ . (2003). J. Biol. Chem., (epub ahead of print).

  • Shtiegman K and Yarden Y . (2003). Semin. Cancer Biol., 13, 29–40.

  • Solomon B, Hagekyriakou J, Trivett MK, Stacker SA, McArthur GA and Cullinane C . (2003). Int. J. Radiat. Oncol. Biol. Phys., 55, 713–723.

  • Swantek JL and Baserga R . (1999). Endocrinology, 140, 3163–3169.

  • Tenev T, Keilhack H, Tomic S, Stoyanov B, Stein-Gerlach M, Lammers R, Krivtsov AV, Ullrich A and Bohmer FD . (1997). J. Biol. Chem., 272, 5966–5973.

  • Tiganis T . (2002). IUBMB Life, 53, 3–14.

  • Tonks NK and Neel BG . (2001). Curr. Opin. Cell. Biol., 13, 182–195.

  • Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R and Glazer PM . (1997). Cancer Res., 57, 3079–3083.

  • Waterman H, Sabanai I, Geiger B and Yarden Y . (1998). J. Biol. Chem., 273, 13819–13827.

  • Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, Abdulkarim B, Chavaudra N and Bourhis J . (2001). Br. J. Cancer, 85, 2017–2021.

  • Wikstrand CJ, McLendon RE, Friedman AH and Bigner DD . (1997). Cancer Res., 57, 4130–4140.

  • Wilkinson JC and Staros JV . (2002). Biochemistry, 41, 8–14.

  • Withers HR, Taylor JM and Maciejewski B . (1988). Acta Oncol., 27, 131–146.

  • Yacoub A, McKinstry R, Hinman D, Chung T, Dent P and Hagan MP . (2003). Radiat. Res., 159, 439–452.

Download references

Acknowledgements

This work is supported by Grants P01CA72955 and R01CA65896 (to R Schmidt-Ullrich) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services and by the Florence and Hyman Meyers Head and Neck Cancer Research Fund. We thank Susan Kelly for preparation of the figures and Devon Murphy for her editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rupert K Schmidt-Ullrich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt-Ullrich, R., Contessa, J., Lammering, G. et al. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 22, 5855–5865 (2003). https://doi.org/10.1038/sj.onc.1206698

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206698

Keywords

This article is cited by

Search

Quick links